Mission Statement

Founded in 2017, Source Research Foundation (SRF) is a 501(c)(3) non-profit research and educational organization that aims to connect, inspire, and support students who study the epidemiology, phenomenology, and the environmental, cultural and clinical contexts of psychedelic use, and to develop a virtual collaboratory of students, scientists, and community members who are passionate about psychedelic science.

We fully support and adhere to the Statement on Open Science for Psychedelic Medicines and Practices.

Olivia Marcus
Olivia Marcus
Congrats to Olivia Marcus, who was recently selected for a 2018 SRF Connection Award! Olivia has a master’s in public health degree from Columbia University and is currently in a doctoral program in applied medical anthropology at the University of...
Lucia Terpak
Lucia Terpak
Congrats to Lucia Terpak, who was recently selected for a 2018 SRF Source Award! Lucia has a bachelor’s degree from Wake Forest University and is currently in a master’s program in medical anthropology at the University of Colorado at Denver....
Gabrielle Agin-Liebes
Gabrielle Agin-Liebes
Congrats to Gabrielle Agin-Liebes, who was recently selected for a 2018 SRF Connection Award! Gabrielle has a bachelor’s degree from New York University and is currently in a doctoral program in clinical psychology at Palo Alto University. Her project involves...
Brandon Weiss
Brandon Weiss
Congrats to Brandon Weiss, who was recently selected for a 2018 SRF Connection Award! Brandon has a master’s degree from Wake Forest University and is currently in a doctoral program in clinical psychology at the University of Georgia. His project...
Lauren Padgett
Lauren Padgett
Lauren Padgett is an organizer and activist who has been involved in the drug policy reform movement since 2013. She is the Development Director at Students for Sensible Drug Policy, a nonprofit organization that mobilizes 5,000 students in 33 countries to change harmful and punitive drug policies, especially those that directly harm students and young people. Lauren joined the SSDP team in 2014 and has been with the organization through its largest period of growth. At 29, she became the youngest Development Director ever to work in drug policy. She is primarily responsible for major donor stewardship, grant writing, and crafting and executing SSDP’s annual strategic fundraising plan.
Rafael L. Lancelotta, MS.
Rafael L. Lancelotta, MS.
Founding Director (Secretary)
Rafael Lancelotta is currently working as a psychedelic-assisted therapist at Innate Path in Denver. He is interested in the use of psychedelics towards greater levels of resiliency, mental health, openness, and social/systemic change. He is also interested in the investigation of techniques used in the counseling relationship that may deepen and enhance the benefits of psychedelic-assisted therapy integration.
Kathleen A. Davis
Kathleen A. Davis
Founding Director and Registered Agent (Treasurer)
Kathleen A Davis is a United States Army Veteran who served in the Women’s Army Corps during the Vietnam War. She studied psychology at the University of California in San Diego prior to working in law enforcement and security for many years in Las Vegas, Nevada.
Dawn D. Davis, MA.
Dawn D. Davis, MA.
Founding Director
Dawn D. Davis is Tribal person belonging to the Shoshone-Bannock Tribes. She holds a master's degree from the University of Arizona where she researched the conservation and sustainability of peyote, an Indigenous medicine, within its natural habitat.
Alan K. Davis, PhD.
Alan K. Davis, PhD.
Founding Director (President)
Dr. Alan K Davis is a postdoctoral research fellow at Johns Hopkins University where his research focuses on the epidemiology, phenomenology, and psychology of recreational and medical use of licit and illicit substances.
Mariana M. Cajaiba, MD.
Mariana M. Cajaiba, MD.
Founding Director
Dr. Mariana M. Cajaiba is a physician trained in Clinical Oncology and Anatomic Pathology who currently holds an appointment as Associate Professor at Northwestern University Feinberg School of Medicine.
Joseph P. Barsuglia, PhD.
Joseph P. Barsuglia, PhD.
Founding Director
Dr. Joseph Peter Barsuglia is a research psychologist and a former Christian pastor. He recently served as the Director of Clinical Research and Assessment at Crossroads Treatment Center in Mexico, which utilized the psychedelic compounds Ibogaine and 5-MeO-DMT in the treatment of addiction and for psychospiritual development.
Lynnette A. Averill, PhD.
Lynnette A. Averill, PhD.
Founding Director
Dr. Lynnette “Nette” A. Averill is a clinical research psychologist at the National Center for PTSD-Clinical Neurosciences Division (NCPTSD-CND) at the VA Connecticut and Yale School of Medicine Department of Psychiatry.
Brooke J. Arterberry, PhD.
Brooke J. Arterberry, PhD.
Founding Director (Vice President)
Dr. Brooke J. Arterberry is currently an Assistant Professor in the Department of Psychology at Iowa State University. Dr. Arterberry completed her Postdoctoral Training at the University of Michigan Addiction Center in the Department of Psychiatry and the Ann Arbor VA. She received her Ph.D. in Counseling Psychology at the University of Missouri, M.S. in Counseling and Counselor Education at Indiana University, and B.A. in Psychology and English at the University of Southern Indiana. Her research focuses on understanding the developmental risks associated with substance use (e.g., alcohol and cannabis use/co-use) using a socio-ecological perspective and polysubstance use framework.